A. López-Chávez

发表

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.

F. Cappuzzo, D. Gandara, D. Planchard, 2015, The Lancet. Oncology.

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

G. Giaccone, S. Steinberg, E. Szabo, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase I / II study of sepantronium bromide ( YM 155 , survivin suppressor ) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer

G. Giaccone, S. Steinberg, E. Szabo, 2013 .

Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

D. Citrin, John C. Morris, J. Janik, 2011, Molecular Cancer.

Atezolizumab for First‐Line Treatment of Metastatic Nonsquamous NSCLC

Federico Cappuzzo, M. Socinski, F. Cappuzzo, 2018, The New England journal of medicine.

A randomized phase 2 trial of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with erlotinib in EGFR wild-type NSCLC patients.

L. Sequist, G. MacBeath, Keunchil Park, 2014 .

Young male with fanconi anemia and EGFR-mutant non-small-cell lung cancer.

E. Cathcart-Rake, A. López-Chávez, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors.

G. Giaccone, E. Szabo, J. Trepel, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HGF Airway Over-expression Leads to Enhanced Pulmonary Vascularization without Induction of VEGF.

J. Siegfried, A. López-Chávez, Cassandra Henry, 2012, Current angiogenesis.

From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma.

Yi-Song Wang, G. Giaccone, Anish Thomas, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Reply to A. Stenzinger et al.

G. Giaccone, Anish Thomas, A. López-Chávez, 2015, Journal of Clinical Oncology.

Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years.

G. Giaccone, C. Moran, L. Nieman, 2012, The Journal of clinical endocrinology and metabolism.

Overall survival (OS) analysis of IMpower150, a randomized Ph 3 study of atezolizumab (atezo) + chemotherapy (chemo) ± bevacizumab (bev) vs chemo + bev in 1L nonsquamous (NSQ) NSCLC.

M. Socinski, F. Cappuzzo, D. Moro-Sibilot, 2018 .

A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study

G. Giaccone, S. Steinberg, E. Szabo, 2014, Clinical Cancer Research.

LBA1_PRPrimary PFS and safety analyses of a randomized phase III study of carboplatin + paclitaxel +/− bevacizumab, with or without atezolizumab in 1L non-squamous metastatic nsclc (IMPOWER150)

M. Socinski, D. Moro-Sibilot, F. Barlesi, 2017 .

First‐Line Atezolizumab plus Chemotherapy in Extensive‐Stage Small‐Cell Lung Cancer

A. Mansfield, T. Mok, Melissa L. Johnson, 2018, The New England journal of medicine.

Systemic issues in small cell lung cancer.

A. Sandler, A. López-Chávez, A. Lopez‐Chavez, 2012, Current problems in cancer.

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.

Udayan Guha, Seth M Steinberg, Keith Killian, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry

G. Giaccone, M. Raffeld, L. Xi, 2011, Oncogene.

Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Sorafenib

G. Giaccone, S. Steinberg, P. Choyke, 2011, Clinical Cancer Research.

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC.

D. Gerber, P. Swanson, A. Dowlati, 2017, Lung cancer.

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer

C. Corless, E. Cathcart-Rake, A. López-Chávez, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.

L. Sequist, Keunchil Park, R. Doebele, 2019, The oncologist.

Bevacizumab Maintenance in Patients with Advanced Non–Small-Cell Lung Cancer, Clinical Patterns, and Outcomes in the Eastern Cooperative Oncology Group 4599 Study: Results of An Exploratory Analysis

J. Schiller, A. Dowlati, A. Sandler, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EGFR Mutations in Latinos From the United States and Latin America

G. Giaccone, S. Steinberg, M. Raffeld, 2016, Journal of Global Oncology.

Targeted therapies: Importance of patient selection for EGFR TKIs in lung cancer

G. Giaccone, A. López-Chávez, 2010, Nature Reviews Clinical Oncology.

Treatment receipt and outcomes among lung cancer patients with depression.

S. Thielke, C. Slatore, A. López-Chávez, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)

L. Sequist, A. Chiang, S. Gettinger, 2016 .

Patient-reported outcomes (PROs) in the randomized, phase III IMpower150 study of atezolizumab (atezo) + chemotherapy (chemo) ± bevacizumab (bev) vs chemo + bev in 1L nonsquamous metastatic NSCLC (mNSCLC).

M. Socinski, A. Sandler, M. Reck, 2018 .

A phase I study of paclitaxel, carboplatin, and YM155 (survivin suppressor) in subjects with solid tumors.

G. Giaccone, A. Rajan, R. Kelly, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.